Рет қаралды 8,276
Immunotherapy has revolutionized cancer treatment over the last few decades, though not for glioblastoma - the most common and deadly malignant brain tumor. However, Northwestern Medicine neurosurgeon Adam Sonabend, MD, shares promising research on the potential benefits of immunotherapy for certain glioblastoma patients.